antiviral drugs

In 2022, COVID-19 Vaccines Face the Red Queen Challenge

Pfizer Confirms COVID Pill’s Results, Potency Versus Omicron

Pfizer Says Its New Antiviral Pill Cuts Risk of Severe COVID by 89%

Molnupiravir: Merck Greenlights Generic Manufacturing of Its COVID Pill

Molnupiravir: Merck Says Experimental Pill Cuts Worst Effects of COVID-19

As ICMR Revises COVID Guidelines, India Can Exit the Thrall of Ivermectin, HCQ

We Need Antimicrobial Stewardship To Contain Drug Resistance Worsened By COVID-19